Creo Medical Group PLC Strategic Asset Allocation Index
Creo Medical Group PLC strategic asset allocation index. Creo Medical Group PLC (CREO) has a Strategic Asset Allocation Index of 14.1% as of June 2023. Strategic assets (PP&E of GBX9.70 Million plus long-term investments of GBX-) total GBX9.70 Million, measured against net assets of GBX69.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Creo Medical Group PLC (CREO) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Creo Medical Group PLC (2007–2021)
Strategic asset allocation index of Creo Medical Group PLC from 2007 to 2021. This chart shows how Creo Medical Group PLC's Strategic Asset Allocation Index has evolved across 12 annual periods from 2007 to 2021. As of June 2023, the index stands at 14.1%, representing strategic assets of GBX9.70 Million against net assets of GBX69.00 Million GBX. Check CREO tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Creo Medical Group PLC Strategic Asset Allocation Index by Year (2007–2021)
Creo Medical Group PLC strategic asset allocation index by year from 2007 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Creo Medical Group PLC from 2007 to 2021, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Creo Medical Group PLC.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 11.7% | GBX8.60 Million | GBX8.60 Million | GBX- | GBX73.32 Million | ▲ +6.4 pp |
| 2020 | 5.4% | GBX3.38 Million | GBX3.38 Million | GBX- | GBX62.81 Million | ▲ +3.8 pp |
| 2019 | 1.6% | GBX1.30 Million | GBX1.30 Million | GBX- | GBX82.66 Million | ▼ -0.3 pp |
| 2018 | 1.9% | GBX906.26K | GBX906.26K | GBX- | GBX47.71 Million | ▼ -9.7 pp |
| 2018 | 11.6% | GBX853.00K | GBX853.00K | GBX- | GBX7.33 Million | ▲ +9.4 pp |
| 2017 | 2.2% | GBX325.02K | GBX325.02K | GBX- | GBX14.65 Million | ▼ -12.5 pp |
| 2016 | 14.7% | GBX239.75K | GBX239.75K | GBX- | GBX1.63 Million | ▲ +8.5 pp |
| 2016 | 6.2% | GBX199.36K | GBX199.36K | GBX- | GBX3.22 Million | ▼ -10.6 pp |
| 2015 | 16.8% | GBX126.00K | GBX126.00K | GBX- | GBX748.41K | ▲ +6.7 pp |
| 2014 | 10.1% | GBX139.00K | GBX139.00K | GBX- | GBX1.37 Million | ▲ +5.7 pp |
| 2008 | 4.4% | GBX5.00K | GBX5.00K | GBX- | GBX113.00K | ▼ -45.6 pp |
| 2007 | 50.0% | GBX6.00K | GBX6.00K | GBX- | GBX12.00K | — |